Jiayi Qin

Jiayi Qin

Auto-generated profile, based on publicly available information

Jiayi Qin

Department of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
LXLixing Xu
Lixing Xu
EBEnhe Bai
Enhe Bai
YZYangbo Zhu
Yangbo Zhu
JQJiayi Qin
Jiayi Qin
XDXiao Du
Xiao Du
HHHaiqin Huang
Haiqin Huang
Gastric ulcer is one of the most common gastrointestinal diseases, and natural products have obvious advantages in the treatment of gastrointestinal diseases. Baicalin (Bai) extracted from scutellaria baicalensis exhibits anti-inflammatory, antioxidant, and anti-apoptotic activities. Herein, a pH-responsive sodium alginate/polyaspartate/CaCO3 (SA/PASP@CaCO3) in situ hydrogel was established for the oral delivery of Bai. In this study, we detected the gelling properties, mechanical strength, in vitro erosion, and in vitro release behavior of the hydrogels. Meanwhile, the efficiency of Bai/SA/PASP@CaCO3 hydrogel on ethanol-induced acute gastric ulcers, acetic acid-induced chronic gastric ulcers, and H2O2-stimulated human gastric epithelial GES-1 cells was explored. The pathological examination revealed that Bai-loaded hydrogel alleviated acute and chronic gastric ulcers. In vivo and in vitro results further confirmed that Bai/SA/PASP@CaCO3 in situ hydrogels significantly relieved oxidative stress injury. Moreover, through Western blot assay, Bai/SA/PASP@CaCO3 hydrogel was also found to dramatically increase the proteins levels of NRF2, HO-1, and Bcl2, and reduce levels of p-JNK, cleaved-caspase-3 and Bax; through flow cytometry, it was observed to significantly inhibit the H2O2-induced apoptosis of GES-1 cells. Importantly, the Bai/SA/PASP@CaCO3 in situ hydrogel system showed better anti-gastric ulcer efficiency than free drug, and could serve as a potential drug delivery system for the clinical treatment of gastric ulcers.

21 January 2021 in Bio-Design and Manufacturing
Verified
Journal Article
Closed access
PDF file
JQJiayi Qin
Jiayi Qin
YZYangbo Zhu
Yangbo Zhu
DZDongsheng Zheng
Dongsheng Zheng
QZQingwei Zhao
Qingwei Zhao

18 March 2021 in Pharmaceutical Development and Technology
Verified
Journal Article
Closed access
KSKang Sha
Kang Sha
QMQianfang Ma
Qianfang Ma
HVHanitrarimalala Veroniaina
Hanitrarimalala Veroniaina
XQXiaole Qi
Xiaole Qi
JQJiayi Qin
Jiayi Qin
ZWZhenghong Wu
Zhenghong Wu
Solidification of self-microemulsifying drug delivery systems (SMEDDS) is one of the major trends to promote the transformation of self-microemulsion technology into industrialization. Here, a preliminary curcumin SMEDDS formulation was constructed to improve the druggability of curcumin, through the determination of equilibrium solubility determination, self-emulsifying grading assessment, and pseudo-ternary phase diagrams drafting. Furthermore, the optimal curcumin SMEDDS formulation consisted of 10% Ethyl oleate, 57.82% Cremophor RH 40, and 32.18% Transcutol P was obtained by the simplex lattice design. Besides, curcumin solid self-microemulsifying drug delivery system (S-SMEDDS) was developed by the extrusion and spheronization process to achieve the solidification of SMEDDS. The formulation of curcumin S-SMEDDS pellets was screened by the single factor experiment and the process parameters were investigated using the orthogonal optimization method. Subsequently, curcumin S-SMEDDS pellets were evaluated by apparent morphology characterization, redispersibility study, drug release behavior, and pharmacokinetic evaluation. Results from the pharmacokinetic study in rabbits showed that the AUC0–τ of the curcumin S-SMEDDS pellets and curcumin suspension were 5.91 ± 0.28 µg/mL·h and 2.05 ± 0.04 µg/mL·h, while the relative bioavailability was 289.30%. These studies demonstrated that S-SMEDDS pellets can be a promising strategy for curcumin industrialized outputs.

24 March 2025 in Journal of Controlled Release
Verified
Journal Article
Closed access
LXLixing Xu
Lixing Xu
SLShanshan Li
Shanshan Li
SWShen Wan
Shen Wan
ZLZhikuan Liu
Zhikuan Liu
YZYuxin Zhong
Yuxin Zhong
HHHaiqin Huang
Haiqin Huang

16 April 2024 in Journal of Science: Advanced Materials and Devices
Verified
Journal Article
Open access
YZYangbo Zhu
Yangbo Zhu
HHHaiqin Huang
Haiqin Huang
QZQingwei Zhao
Qingwei Zhao
JQJiayi Qin
Jiayi Qin
The lack of effective diagnostic and therapeutic techniques is a crucial cause of the high clinical mortality for malignancy. Notably, self-propelled micro/nanomotors are expected to address the drawbacks of conventional nanoparticles in tumor diagnosis and therapy. The special locomotion property ensures the high efficiency of micro/nanomotors in term of rapid distribution, deep penetration, and targeted delivery. Hence, in this review, the motion mechanism and the controllability of speed and direction of the micro/nanomotors were described, as well as the advantages regarding the enhancement of biological barrier crossing (overcoming blood flow obstacles, tumor microenvironment barriers), targeting delivery and deep penetration in the tumor. The most recent advances in micro/nanomotor contributions were comprehensively summarized to various medical imaging technologies, biosensing techniques, and therapeutic approaches, especially for the combination therapy and integration of diagnosis and treatment based on multifunctional micro/nanomotors. Furthermore, challenges for developing practical micro/nanomotors were discussed along with future directions from the clinicians' perspective, which is promised to speed up the clinical translation process and contribute to efficient tumor diagnosis and therapy.

21 July 2025 in Bio-Design and Manufacturing
Verified
Journal Article
Open access
PDF file
YZYangbo Zhu
Yangbo Zhu
Pengfei CuiPengfei Cui
Pengfei Cui
LZLijuan Zhao
Lijuan Zhao
QLQi Ling
Qi Ling
JQJiayi Qin
Jiayi Qin
The therapeutic efficacy of hepatocellular carcinoma (HCC) medication is severely compromised by inadequate drug delivery to tumor sites. Herein, we fabric